Cargando…
Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia
INTRODUCTION: Insulin degludec (degludec) has proven benefits in type 2 diabetes (T2D), in terms of improved glycaemic control, low risk of hypoglycaemia, and flexibility in dosing time. This prospective non-interventional UPDATES study aimed to investigate whether results obtained from randomised c...
Autores principales: | AlMalki, Mussa H., Aldesokey, Hossam, Alkhafaji, Dania, Alsheikh, Abdulrahman, Braae, Uffe Christian, Lehrskov, Lars Lang, Magawry, Waleed, Yahia, Moataz, Haroun, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685061/ https://www.ncbi.nlm.nih.gov/pubmed/36417058 http://dx.doi.org/10.1007/s12325-022-02366-0 |
Ejemplares similares
-
Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia
por: Fallatah, Walla, et al.
Publicado: (2022) -
Serum heavy metals and hemoglobin related compounds in Saudi Arabia firefighters
por: Al-Malki, Abdulrahman L
Publicado: (2009) -
The Clinical Impact of Switching Basal Insulin to Insulin Degludec in Patients With Diabetes in Saudi Arabia: A Retrospective One-Group Pretest-Posttest Design Study
por: Althagafi, Abdulhamid, et al.
Publicado: (2022) -
Improving Disaster Readiness and the Response of Nurses in Saudi Arabia
por: Al Harthi, Manal, et al.
Publicado: (2021) -
The impact of obesity on hospitalized patients with COVID-19 infection in the Eastern Province of Saudi Arabia
por: AlKhafaji, Dania, et al.
Publicado: (2022)